메뉴 건너뛰기




Volumn , Issue , 2007, Pages 525-541

Adult Acute Lymphoblastic Leukaemia

Author keywords

Acute lymphoblastic leukaemia (ALL); Blood substitution; Cell surface marker analysis; Differential diagnosis; Infection management

Indexed keywords


EID: 84890573492     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987056.ch32     Document Type: Chapter
Times cited : (1)

References (60)
  • 2
    • 0036464686 scopus 로고    scopus 로고
    • Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study
    • Annino L, Vegna ML, Camera A et al. (2002) Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood 99: 863-71.
    • (2002) Blood , vol.99 , pp. 863-871
    • Annino, L.1    Vegna, M.L.2    Camera, A.3
  • 3
    • 33750369485 scopus 로고    scopus 로고
    • Phenotype predicts outcome after allogeneic stem cell transplantation in adult high risk ALL patients
    • abstract #1719
    • Arnold R, Beelen D, Bunjes D et al. (2003) Phenotype predicts outcome after allogeneic stem cell transplantation in adult high risk ALL patients. Blood 102: abstract #1719.
    • (2003) Blood , vol.102
    • Arnold, R.1    Beelen, D.2    Bunjes, D.3
  • 4
    • 0036936830 scopus 로고    scopus 로고
    • Nonmyeloablative stem cell transplantation in adults with highrisk ALL may be effective in early but not in advanced disease
    • Arnold R, Massenkeil G, Bornhauser M, Ehninger et al. (2002) Nonmyeloablative stem cell transplantation in adults with highrisk ALL may be effective in early but not in advanced disease. Leukemia 16: 2423-8.
    • (2002) Leukemia , vol.16 , pp. 2423-2428
    • Arnold, R.1    Massenkeil, G.2    Bornhauser, M.3    Ehninger4
  • 5
    • 0029123732 scopus 로고
    • Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation
    • Attal M, Blaise D, Marit G et al. (1995) Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. Blood 86: 1619-28.
    • (1995) Blood , vol.86 , pp. 1619-1628
    • Attal, M.1    Blaise, D.2    Marit, G.3
  • 6
    • 0026628059 scopus 로고
    • Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period
    • Bassan R, Battista R, Rohatiner et al. (1992) Treatment of adult acute lymphoblastic leukaemia (ALL) over a 16 year period. Leukemia 6 (Suppl. 2): 186-90.
    • (1992) Leukemia , vol.6 , Issue.SUPPL. 2 , pp. 186-190
    • Bassan, R.1    Battista, R.2    Rohatiner3
  • 7
    • 0030322488 scopus 로고    scopus 로고
    • Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults
    • Bassan R, Lerede T, Barbui T (1996) Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. Haematologica 81: 20-36.
    • (1996) Haematologica , vol.81 , pp. 20-36
    • Bassan, R.1    Lerede, T.2    Barbui, T.3
  • 8
    • 4744355524 scopus 로고    scopus 로고
    • Early tumor kinetics in adult acute lymphoblastic leukemia (ALL) has high prognostic impact
    • Abstract #215
    • Brueggemann M, Raff T, Gökbuget N et al. (2003) Early tumor kinetics in adult acute lymphoblastic leukemia (ALL) has high prognostic impact. Blood 102: 11 (Abstract #215).
    • (2003) Blood , vol.102 , pp. 11
    • Brueggemann, M.1    Raff, T.2    Gökbuget, N.3
  • 9
    • 0034035040 scopus 로고    scopus 로고
    • Systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies: current serological and molecular diagnostic methods
    • Buchheidt D, Skladny H, Baust C, Hehlmann R (2000) Systemic infections with Candida sp. and Aspergillus sp. in immunocompromised patients with hematological malignancies: current serological and molecular diagnostic methods. Chemotherapy 46:219-28.
    • (2000) Chemotherapy , vol.46 , pp. 219-228
    • Buchheidt, D.1    Skladny, H.2    Baust, C.3    Hehlmann, R.4
  • 10
    • 0035869381 scopus 로고    scopus 로고
    • Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome
    • Cornelissen JJ, Carston M, Kollman C et al. (2001) Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome. Blood 97: 1572-7.
    • (2001) Blood , vol.97 , pp. 1572-1577
    • Cornelissen, J.J.1    Carston, M.2    Kollman, C.3
  • 11
    • 0038724253 scopus 로고    scopus 로고
    • Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies
    • Cornely OA, Ullmann AJ, Karthaus M (2003) Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies. Blood 101: 3365-72.
    • (2003) Blood , vol.101 , pp. 3365-3372
    • Cornely, O.A.1    Ullmann, A.J.2    Karthaus, M.3
  • 12
    • 0029135378 scopus 로고
    • The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia
    • Cortes J, O'Brien SM, Pierce S et al. (1995) The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood 86: 2091-7.
    • (1995) Blood , vol.86 , pp. 2091-2097
    • Cortes, J.1    O'Brien, S.M.2    Pierce, S.3
  • 13
    • 0025797066 scopus 로고
    • Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study
    • Cuttner J, Mick R, Budman DR et al. (1991) Phase III trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study. Leukemia 5: 425-31.
    • (1991) Leukemia , vol.5 , pp. 425-431
    • Cuttner, J.1    Mick, R.2    Budman, D.R.3
  • 14
    • 0031019713 scopus 로고    scopus 로고
    • Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia
    • Dekker AW, van't Veer MB, Sizoo W et al. (1997) Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia. Journal of Clinical Oncology 15: 476-82.
    • (1997) Journal of Clinical Oncology , vol.15 , pp. 476-482
    • Dekker, A.W.1    van't Veer, M.B.2    Sizoo, W.3
  • 15
    • 0027485786 scopus 로고
    • Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia
    • Durrant IJ (1993) Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia. British Journal of Haematology 85: 84-92.
    • (1993) British Journal of Haematology , vol.85 , pp. 84-92
    • Durrant, I.J.1
  • 16
    • 0030731212 scopus 로고    scopus 로고
    • Intensification of treatment for adults with acute lymphoblastic leukaemia: results of UK Medical Research Council randomized trial UKALL XA
    • Durrant IJ, Prentice HG, Richards SM (1997) Intensification of treatment for adults with acute lymphoblastic leukaemia: results of UK Medical Research Council randomized trial UKALL XA. British Journal of Haematology 99: 84-92.
    • (1997) British Journal of Haematology , vol.99 , pp. 84-92
    • Durrant, I.J.1    Prentice, H.G.2    Richards, S.M.3
  • 17
    • 0025947889 scopus 로고
    • The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B
    • Ellison RR, Mick R, Cuttner J et al. (1991) The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B. Journal of Clinical Oncology 9: 2002-15.
    • (1991) Journal of Clinical Oncology , vol.9 , pp. 2002-2015
    • Ellison, R.R.1    Mick, R.2    Cuttner, J.3
  • 18
    • 0028837561 scopus 로고
    • Proposals for the immunological classification of acute leukemias
    • European Group for the Immunological Characterization of Leukemia (EGIL)
    • European Group for the Immunological Characterization of Leukemia (EGIL), Bene MC, Castoldi G et al. (1995) Proposals for the immunological classification of acute leukemias. Leukemia 9:1783-6.
    • (1995) Leukemia , vol.9 , pp. 1783-1786
    • Bene, M.C.1    Castoldi, G.2
  • 19
    • 0027436249 scopus 로고
    • Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy
    • Fiere D, Lepage E, Sebban C et al. (1993) Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. Journal of Clinical Oncology 11: 1990-2001.
    • (1993) Journal of Clinical Oncology , vol.11 , pp. 1990-2001
    • Fiere, D.1    Lepage, E.2    Sebban, C.3
  • 20
    • 0030811665 scopus 로고    scopus 로고
    • Granulocyte colonystimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia-a randomized phase-III study
    • Geissler K, Koller E, Hubmann E et al. (1997) Granulocyte colonystimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia-a randomized phase-III study. Blood 90: 590-6.
    • (1997) Blood , vol.90 , pp. 590-596
    • Geissler, K.1    Koller, E.2    Hubmann, E.3
  • 21
    • 0031801173 scopus 로고    scopus 로고
    • Meningeosis leukaemia in adult acute lymphoblastic leukaemia
    • Gökbuget N, Hoelzer D (1998) Meningeosis leukaemia in adult acute lymphoblastic leukaemia. Journal of Neuro-Oncology 38:167-80.
    • (1998) Journal of Neuro-Oncology , vol.38 , pp. 167-180
    • Gökbuget, N.1    Hoelzer, D.2
  • 22
    • 0036201923 scopus 로고    scopus 로고
    • The role of high-dose cytarabine in induction therapy for adult ALL
    • Gökbuget N, Hoelzer D (2002) The role of high-dose cytarabine in induction therapy for adult ALL. Leukemia Research 26: 473-6.
    • (2002) Leukemia Research , vol.26 , pp. 473-476
    • Gökbuget, N.1    Hoelzer, D.2
  • 23
    • 0038777313 scopus 로고    scopus 로고
    • Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia
    • Gökbuget N, Hoelzer D (2003) Non-myeloablative conditioning before allogeneic stem cell transplantation in adult acute lymphoblastic leukemia. Haematologica 88: 484-6.
    • (2003) Haematologica , vol.88 , pp. 484-486
    • Gökbuget, N.1    Hoelzer, D.2
  • 24
    • 1842424992 scopus 로고    scopus 로고
    • Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects
    • Gökbuget N, Hoelzer D (2004) Treatment with monoclonal antibodies in acute lymphoblastic leukemia: current knowledge and future prospects. Annals of Hematology 83: 201-5.
    • (2004) Annals of Hematology , vol.83 , pp. 201-205
    • Gökbuget, N.1    Hoelzer, D.2
  • 26
    • 4043180248 scopus 로고    scopus 로고
    • Prospective risk stratification based on minimal residual disease (MRD) Is feasible in adult ALL but limited by a high proportion of MRDintermediate risk
    • Abstract #1373
    • Gökbuget N, Raff T, Brueggemann M et al. (2003) prospective risk stratification based on minimal residual disease (MRD) Is feasible in adult ALL but limited by a high proportion of MRDintermediate risk. Blood 102: Abstract #1373.
    • (2003) Blood , vol.102
    • Gökbuget, N.1    Raff, T.2    Brueggemann, M.3
  • 27
    • 0036040439 scopus 로고    scopus 로고
    • High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia
    • Hallbook H, Simonsson B, Ahlgren T et al. (2002) High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia. British Journal of Haematology 118: 748-54.
    • (2002) British Journal of Haematology , vol.118 , pp. 748-754
    • Hallbook, H.1    Simonsson, B.2    Ahlgren, T.3
  • 28
    • 0003325202 scopus 로고    scopus 로고
    • Characteristics, outcome and risk factors in adult T-lineage acute lymphoblastic leukemia (ALL)
    • Hoelzer D, Arnold R, Freund M et al. (1999) Characteristics, outcome and risk factors in adult T-lineage acute lymphoblastic leukemia (ALL). Blood 94: 2926a.
    • (1999) Blood , vol.94
    • Hoelzer, D.1    Arnold, R.2    Freund, M.3
  • 29
    • 4344666976 scopus 로고    scopus 로고
    • Short Intensive chemotherapy with rituximab seems successful in Burkitt NHL, mature B-ALL and other high-grade B-NHL
    • Abstract #236
    • Hoelzer D, Baur K.-H, Giagounidis A et al. (2003) Short Intensive chemotherapy with rituximab seems successful in Burkitt NHL, mature B-ALL and other high-grade B-NHL. Blood 102: Abstract #236.
    • (2003) Blood , vol.102
    • Hoelzer, D.1    Baur, K.-H.2    Giagounidis, A.3
  • 30
    • 13344285351 scopus 로고    scopus 로고
    • Improved outcome in adult B-cell acute lymphoblastic leukemia
    • Hoelzer D, Ludwig W.-D, Thiel E et al. (1996) Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 87: 495-508.
    • (1996) Blood , vol.87 , pp. 495-508
    • Hoelzer, D.1    Ludwig, W.-D.2    Thiel, E.3
  • 31
    • 0027426201 scopus 로고
    • Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84)
    • Hoelzer D, Thiel E, Ludwig WD et al. (1993) Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). Leukemia 17 (Suppl. 2): 130-4.
    • (1993) Leukemia , vol.17 , Issue.SUPPL. 2 , pp. 130-134
    • Hoelzer, D.1    Thiel, E.2    Ludwig, W.D.3
  • 32
    • 0037087226 scopus 로고    scopus 로고
    • Guidelines for the use of antimicrobial agents in neutropenic patients with cancer
    • Hughes WT, Armstrong D, Bodey GP et al. (2002) Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical Infectious Diseases 34: 730.
    • (2002) Clinical Infectious Diseases , vol.34 , pp. 730
    • Hughes, W.T.1    Armstrong, D.2    Bodey, G.P.3
  • 33
    • 0027437548 scopus 로고
    • Granulocytestimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia first remission
    • Kantarjian HM, Estey E, O'Brien S et al. (1993) Granulocytestimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia first remission. Cancer 72:2950-5.
    • (1993) Cancer , vol.72 , pp. 2950-2955
    • Kantarjian, H.M.1    Estey, E.2    O'Brien, S.3
  • 34
    • 0033964380 scopus 로고    scopus 로고
    • Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
    • Kantarjian HM, O'Brien S, Smith TL et al. (2000) Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. Journal of Clinical Oncology 18: 547-61.
    • (2000) Journal of Clinical Oncology , vol.18 , pp. 547-561
    • Kantarjian, H.M.1    O'Brien, S.2    Smith, T.L.3
  • 35
    • 0003317661 scopus 로고    scopus 로고
    • 2-amino-9-B-Darabinosyl-6-methoxy-9H-guanine (GW506U; Compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies
    • Kurtzberg J, Keating M, Moore JO et al. (1996) 2-amino-9-B-Darabinosyl-6-methoxy-9H-guanine (GW506U; Compound 506U) is highly active in patients with T-cell malignancies: Results of a phase I trial in pediatric and adult patients with refractory hematological malignancies. Blood 88: 2666a.
    • (1996) Blood , vol.88
    • Kurtzberg, J.1    Keating, M.2    Moore, J.O.3
  • 36
    • 0026468232 scopus 로고
    • Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study
    • Labopin M, Gorin NC (1992) Autologous bone marrow transplantation in 2502 patients with acute leukemia in Europe: a retrospective study. Leukemia 6: 95-9.
    • (1992) Leukemia , vol.6 , pp. 95-99
    • Labopin, M.1    Gorin, N.C.2
  • 37
    • 0028938844 scopus 로고
    • A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811
    • Larson RA, Dodge RK, Burns CP et al. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 85: 2025-37.
    • (1995) Blood , vol.85 , pp. 2025-2037
    • Larson, R.A.1    Dodge, R.K.2    Burns, C.P.3
  • 38
    • 0032170428 scopus 로고    scopus 로고
    • A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111
    • Larson RA, Dodge RK, Linker CA et al. (1998) A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111. Blood 92: 1556-64.
    • (1998) Blood , vol.92 , pp. 1556-1564
    • Larson, R.A.1    Dodge, R.K.2    Linker, C.A.3
  • 39
    • 0035886710 scopus 로고    scopus 로고
    • Brief-duration highintensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251
    • Lee EJ, Petroni GR, Schiffer CA et al. (2001) Brief-duration highintensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251. Journal of Clinical Oncology 19: 4014-22.
    • (2001) Journal of Clinical Oncology , vol.19 , pp. 4014-4022
    • Lee, E.J.1    Petroni, G.R.2    Schiffer, C.A.3
  • 40
    • 0030940214 scopus 로고    scopus 로고
    • Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL)
    • Linker CA (1997) Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL). Leukemia 11: S24-7.
    • (1997) Leukemia , vol.11
    • Linker, C.A.1
  • 41
    • 0026024847 scopus 로고
    • Improved results of an intensified therapy in adult acute lymphocytic leukemia
    • Lluesma-Gonalons M, Pavlovsky S, Santarelli MT et al. (1991) Improved results of an intensified therapy in adult acute lymphocytic leukemia. Annals of Oncology 2: 33-9.
    • (1991) Annals of Oncology , vol.2 , pp. 33-39
    • Lluesma-Gonalons, M.1    Pavlovsky, S.2    Santarelli, M.T.3
  • 42
    • 0032530350 scopus 로고    scopus 로고
    • Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia:results of the German multicenter trials GMALL 03/87 and 04/89
    • Ludwig W.-D, Rieder H, Bartram CR et al. (1998) Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia:results of the German multicenter trials GMALL 03/87 and 04/89. Blood 92: 1898-1909.
    • (1998) Blood , vol.92 , pp. 1898-1909
    • Ludwig, W.-D.1    Rieder, H.2    Bartram, C.R.3
  • 44
    • 0037512358 scopus 로고    scopus 로고
    • Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study
    • Martino R, Giralt S, Caballero MD et al. (2003) Allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning in acute lymphoblastic leukemia: a feasibility study. Haematologica 88: 555-60.
    • (2003) Haematologica , vol.88 , pp. 555-560
    • Martino, R.1    Giralt, S.2    Caballero, M.D.3
  • 45
    • 0037105560 scopus 로고    scopus 로고
    • A phase II study of imatinib mesylate (Glivec) in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias
    • Ottmann OG, Druker BJ, Sawyers CL et al. (2002) A phase II study of imatinib mesylate (Glivec) in patients with relapsed or refractory Philadelphia chromosome-positive acute lymphoid leukemias. Blood 100: 1965-71.
    • (2002) Blood , vol.100 , pp. 1965-1971
    • Ottmann, O.G.1    Druker, B.J.2    Sawyers, C.L.3
  • 46
    • 0029067674 scopus 로고
    • Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial
    • Ottmann OG, Hoelzer D, Gracien E et al. (1995) Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: a randomized phase III trial. Blood 86: 444-50.
    • (1995) Blood , vol.86 , pp. 444-450
    • Ottmann, O.G.1    Hoelzer, D.2    Gracien, E.3
  • 47
    • 4043137682 scopus 로고    scopus 로고
    • A randomized trial of imatinib versus chemotherapy induction followed by concurrent imatinib and chemotherapy as first-line treatment in elderly patients with de novo Philadelphia-positive acute lymphoblastic leukemia
    • Abstract #791
    • Ottmann OG, Wassmann B, Gökbuget N et al. (2003) A randomized trial of imatinib versus chemotherapy induction followed by concurrent imatinib and chemotherapy as first-line treatment in elderly patients with de novo Philadelphia-positive acute lymphoblastic leukemia. Blood 102: Abstract #791.
    • (2003) Blood , vol.102
    • Ottmann, O.G.1    Wassmann, B.2    Gökbuget, N.3
  • 48
    • 0031957480 scopus 로고    scopus 로고
    • Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89) Spanish Society of Hematology
    • Ribera JM, Ortega JJ, Oriol A et al. (1998) Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89) Spanish Society of Hematology. Haematologica 83: 222-30.
    • (1998) Haematologica , vol.83 , pp. 222-230
    • Ribera, J.M.1    Ortega, J.J.2    Oriol, A.3
  • 49
    • 0003242016 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL) in first complete remission (CR): Early results from the international ALL trial (MRC UKALL/ECOG E2993)
    • Rowe JM, Richards S, Wiernik PH et al. (1999) Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL) in first complete remission (CR): Early results from the international ALL trial (MRC UKALL/ECOG E2993). Blood 94: 732a.
    • (1999) Blood , vol.94
    • Rowe, J.M.1    Richards, S.2    Wiernik, P.H.3
  • 50
    • 0037205508 scopus 로고    scopus 로고
    • Management of mycoses in patients with hematologic disease and cancer-review of the literature
    • Ruhnke M, Maschmeyer G (2002) Management of mycoses in patients with hematologic disease and cancer-review of the literature. European Journal of Medical Research 7: 227-35.
    • (2002) European Journal of Medical Research , vol.7 , pp. 227-235
    • Ruhnke, M.1    Maschmeyer, G.2
  • 51
    • 0032006125 scopus 로고    scopus 로고
    • Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disorders
    • Slavin S, Nagler A, Naparstek E et al. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic disorders. Blood 91: 756-63.
    • (1998) Blood , vol.91 , pp. 756-763
    • Slavin, S.1    Nagler, A.2    Naparstek, E.3
  • 52
    • 0026721151 scopus 로고
    • Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 and ALL-3)
    • Stryckmans P, de Witte T, Marie JP et al. (1992) Therapy of adult ALL: overview of 2 successive EORTC studies: (ALL-2 and ALL-3). Leukemia 6: 199-203.
    • (1992) Leukemia , vol.6 , pp. 199-203
    • Stryckmans, P.1    de Witte, T.2    Marie, J.P.3
  • 53
    • 0033636586 scopus 로고    scopus 로고
    • Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantatio. A follow-up report of the French protocol LALA 87
    • Thiebaut A, Vernant JP, Degos L et al. (2000) Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantatio. A follow-up report of the French protocol LALA 87. Hematology/Oncology Clinics of North America 14: 1353-66.
    • (2000) Hematology/Oncology Clinics of North America , vol.14 , pp. 1353-1366
    • Thiebaut, A.1    Vernant, J.P.2    Degos, L.3
  • 54
    • 0142074629 scopus 로고    scopus 로고
    • Rituximab and hyper-CVAD for adult Burkitt's (BL) or Burkitt's-like (BLL) leukemia or lymphoma
    • Thomas DA, Cortes J, Giles FJ et al. (2002) Rituximab and hyper-CVAD for adult Burkitt's (BL) or Burkitt's-like (BLL) leukemia or lymphoma. Blood 100: 3022.
    • (2002) Blood , vol.100 , pp. 3022
    • Thomas, D.A.1    Cortes, J.2    Giles, F.J.3
  • 55
    • 0032812621 scopus 로고    scopus 로고
    • Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia
    • Thomas DA, Cortes J, O'Brien S et al. (1999) Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia. Journal of Clinical Oncology 17: 2461-70.
    • (1999) Journal of Clinical Oncology , vol.17 , pp. 2461-2470
    • Thomas, D.A.1    Cortes, J.2    O'Brien, S.3
  • 56
    • 2442615975 scopus 로고    scopus 로고
    • Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
    • Abstract #790
    • Thomas DA, Faderl S, Cortes J et al. (2003) Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate. Blood 102: Abstract #790.
    • (2003) Blood , vol.102
    • Thomas, D.A.1    Faderl, S.2    Cortes, J.3
  • 57
    • 0031951221 scopus 로고    scopus 로고
    • Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin
    • Todeschini G, Tecchio C, Meneghini V et al. (1998) Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. Leukemia 12: 144-9.
    • (1998) Leukemia , vol.12 , pp. 144-149
    • Todeschini, G.1    Tecchio, C.2    Meneghini, V.3
  • 58
    • 84890730832 scopus 로고    scopus 로고
    • Imatinib mesylate induces sustained molecular remissions in philadelphiachromosome positive acute lymphoblastic leukemia (Ph ALL) following molecular relapse after stem cell transplantation (SCT)
    • Abstract 474
    • Wassmann B, Scheuring UJ, Pfeifer H et al. (2003) Imatinib mesylate induces sustained molecular remissions in philadelphiachromosome positive acute lymphoblastic leukemia (Ph ALL) following molecular relapse after stem cell transplantation (SCT). The Hematology Journal 4: 146 (Abstract 474).
    • (2003) The Hematology Journal , vol.4 , pp. 146
    • Wassmann, B.1    Scheuring, U.J.2    Pfeifer, H.3
  • 59
    • 0028298089 scopus 로고
    • Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults
    • Welborn JL (1994) Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults. American Journal of Hematology 45: 341-4.
    • (1994) American Journal of Hematology , vol.45 , pp. 341-344
    • Welborn, J.L.1
  • 60
    • 0028321567 scopus 로고
    • Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment
    • Wernli M, Tichelli A, von Fliedner V et al. (1994) Intensive induction/consolidation therapy without maintenance in adult acute lymphoblastic leukaemia: a pilot assessment. British Journal of Haematology 87: 39-43.
    • (1994) British Journal of Haematology , vol.87 , pp. 39-43
    • Wernli, M.1    Tichelli, A.2    von Fliedner, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.